| Literature DB >> 34050595 |
Ryoichi Maenosono1,2, Yeqi Nian1,3, Jasper Iske1,4, Yang Liu1,5, Koichiro Minami1,2, Tabea Rommel6, Friederike Martin7, Reza Abdi8, Haruhito Azuma2, Bernhard A Rosner9, Hao Zhou1, Edgar Milford8, Abdallah Elkhal1, Stefan G Tullius1.
Abstract
Sex-specific influences have been shown for a variety of diseases. Whether donor or recipient sex and sex hormone levels impact alloimmune responses remains unclear. In unifactorial and multifactorial analyses of more than 400 000 SRTR listed kidney transplant patients, we found that younger female recipients had an inferior death-censored graft survival that was independent of donor sex. In contrast, graft survival was superior in older female recipients, suggesting the impact of recipient sex hormones over chromosomal sex mismatches. Those clinical changes were delineated in experimental skin and heart transplant models showing a prolongation of graft survival in ovariectomized young female recipients. In contrast, graft survival was comparable in ovariectomized and naïve old female recipients. Young ovariectomized mice showed reduced amounts and a compromised T cell proliferation. Deprivation of female hormones dampened the production of interferon (IFN)-γ and interleukin (IL)-17+ by CD4+ T cells while augmenting systemic counts of Tregs. Increasing estradiol concentrations in vitro promoted the switch of naïve CD4+ T cells into Th1 cells; high physiological estradiol concentrations dampening Th1 responses, promoted Tregs, and prolonged graft survival. Thus, clinical observations demonstrate age-specific graft survival patterns in female recipients. Estrogen levels, in turn, impact the fate of T cell subsets, providing relevant and novel information on age- and sex-specific alloimmunity.Entities:
Keywords: basic (laboratory) research/science; endocrinology/diabetology; gender; kidney failure/injury; kidney transplantation/nephrology; organ allocation; organ transplantation in general; rejection: T cell mediated (TCMR); reproductive biology
Mesh:
Substances:
Year: 2021 PMID: 34050595 PMCID: PMC8924905 DOI: 10.1111/ajt.16611
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 9.369